It has been suggested that the defective TCR-dependent activation, characteristic in ADA deficiency, may be exacerbated by this adenosine receptor-mediated immunosuppression (1). This evidence concerns the gene ADA and hyperinsulinemic hypoglycemia, familial, 4.